Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines.

Int J Mol Sci

Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.

Published: April 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Lysine deacetylases, like histone deacetylases (HDACs) and sirtuins (SIRTs), are involved in many regulatory processes such as control of metabolic pathways, DNA repair, and stress responses. Besides robust deacetylase activity, sirtuin isoforms SIRT2 and SIRT3 also show demyristoylase activity. Interestingly, most of the inhibitors described so far for SIRT2 are not active if myristoylated substrates are used. Activity assays with myristoylated substrates are either complex because of coupling to enzymatic reactions or time-consuming because of discontinuous assay formats. Here we describe sirtuin substrates enabling direct recording of fluorescence changes in a continuous format. Fluorescence of the fatty acylated substrate is different when compared to the deacylated peptide product. Additionally, the dynamic range of the assay could be improved by the addition of bovine serum albumin, which binds the fatty acylated substrate and quenches its fluorescence. The main advantage of the developed activity assay is the native myristoyl residue at the lysine side chain avoiding artifacts resulting from the modified fatty acyl residues used so far for direct fluorescence-based assays. Due to the extraordinary kinetic constants of the new substrates (K values in the low nM range, specificity constants between 175,000 and 697,000 Ms) it was possible to reliably determine the IC and K values for different inhibitors in the presence of only 50 pM of SIRT2 using different microtiter plate formats.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138348PMC
http://dx.doi.org/10.3390/ijms24087416DOI Listing

Publication Analysis

Top Keywords

fatty acylated
12
activity assay
8
myristoylated substrates
8
acylated substrate
8
activity
5
continuous fluorescent
4
fluorescent sirtuin
4
sirtuin activity
4
assay
4
assay based
4

Similar Publications

Targeting the intra-erythrocytic life cycle of Plasmodium falciparum unveils antimalarial drug discovery starting points from Drymaria cordata and Macaranga monandra.

J Ethnopharmacol

September 2025

Antimicrobial and Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Faculty of Science, University of Yaoundé I, P.O. Box 812, Yaoundé, Cameroon; Advanced Research & Health Innovation Hub, P.O. Box 20133, Yaoundé, Cameroon. Electronic address: fabrice.boyom@fu

Ethnopharmacological Relevance: Drymaria cordata and Macaranga monandra are two medicinal plants traditionally used in Cameroon to treat malaria, but their scientific validation remains unclear.

Aim Of The Study: To validate the antiplasmodial action of extracts and fractions derived from Drymaria cordata and Macaranga monandra.

Materials And Methods: Aqueous, methanolic, ethanolic, and hydroethanolic extracts of D.

View Article and Find Full Text PDF

SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape.

Nat Commun

September 2025

Shanghai Key Laboratory of Regulatory Biology, Fengxian District Central Hospital-ECNU Joint Center of Translational Medicine, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.

SOX2 is a potent oncodriver for various squamous cancers, but the underlying mechanism is largely unknown. Here we uncover a role of SOX2 in promoting global histone acetylation in esophageal squamous cancer cells (ESCCs). Mechanistic studies reveal that SOX2 promotes global histone acetylation in an AKT-independent manner, and does so by promoting histone acetylation at both SOX2 binding and non-SOX2 binding sites, and accounts for the formation of about half of the super-enhancers.

View Article and Find Full Text PDF

Metabolic syndrome (MetS)-related diseases, such as type 2 diabetes (T2D) and obesity, are among the leading causes of liver damage, and their prevalence poses an increasing clinical challenge. The Mediterranean diet (MD) has shown promising effects in managing MetS, reducing mortality and morbidity. However, the precise biochemical and molecular mechanisms underlying the MD efficacy remain unclear.

View Article and Find Full Text PDF

Background: The Suxiao Jiuxin pill (SJP) is a Chinese patent medicine that is used for the treatment of stable coronary artery disease (SCAD). However, the compatibility mechanism of SJP in treating of SCAD is still unclear. This study aimed to elucidate the serum metabolic profiles of patients with SCAD treated with SJP and to decipher the compatibility mechanism of its effective components, Chuanxiong Rhizoma and borneol.

View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent hepatic metabolic disorder with a rising global incidence. Epigenetic modifications-such as methylation, acetylation, phosphorylation, and ubiquitination-play critical roles in the initiation and progression of MASLD. This study utilized two datasets, GSE89632 and GSE202379.

View Article and Find Full Text PDF